Tech Company Financing Transactions
ARTBIO Funding Round
On 7/29/2025, ARTBIO raised $132 million in Series B funding from B Capital Group, Sofinnova Partners and F-Prime Capital.
Transaction Overview
Company Name
Announced On
7/29/2025
Transaction Type
Venture Equity
Amount
$132,000,000
Round
Series B
Investors
B Capital Group (Lead Investor)
Sofinnova Partners (Lead Investor)
Proceeds Purpose
The company intends to use the funds to support the advancement of ARTBIO's pipeline, including its lead program, AB001, for metastatic castration-resistant prostate cancer, through Phase II clinical trials, and enable continued expansion of the company's supply chain.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Cambridge, MA Undisclosed
USA
Cambridge, MA Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Overview
ARTBIO is redefining cancer care by developing a new class of alpha radioligand therapies (ART) and building the ecosystem that maximizes their potential.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Emanuele Ostuni
Chief Technical Officer
Philippe Dasse
Browse more venture capital transactions:
Prev: 7/29/2025: Centauri Therapeutics venture capital transaction
Next: 7/29/2025: ARX Robotics venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs